Admission Date:  [**2177-10-17**]       Discharge Date:  [**2177-10-28**]  Date of Birth:   [**2105-9-23**]       Sex:  F  Service:  CARDIOTHORACIC SURGERY  HISTORY OF PRESENT ILLNESS:  This is a 72-year-old female patient, with a history of diabetes mellitus, coronary artery disease, peripheral vascular disease, and breast cancer, status post right mastectomy many years ago, who presented to [**Hospital6 1109**] on [**2177-10-7**] with shortness of breath.
In the Emergency Department, she was noted to have EKG changes and elevated cardiac troponin levels, and was started on heparin, Nitroglycerin, aspirin and beta blockers.
She was ultimately transferred to the [**Hospital6 256**] urgently for intra-aortic balloon pump placement due to the severity of her coronary artery disease and anticipation of operating room treatment with coronary artery bypass grafting with Dr. [**First Name (STitle) **] [**Last Name (Prefixes) **].
Coronary artery disease, status post myocardial infarction in the year [**2174**].
Breast cancer, status post mastectomy many years ago.
Lanacane causes skin irritation.
Percocet causes nausea/vomiting.
Motrin causes GI upset.
Tenormin causes hypotension.
Heparin drip at 1,000 U/h.
Aspirin 325 mg qd.
Metoprolol 12.5 mg [**Hospital1 **].
Digoxin 0.125 mg qd.
Neurontin 100 mg [**Hospital1 **].
Protonix 40 mg [**Hospital1 **].
Lantus Insulin 120 U subcutaneously q hs.
HOSPITAL COURSE:  The patient was taken directly to the Cardiac Catheterization Laboratory for intra-aortic balloon placement and subsequently transferred to the Cardiac Surgery Recovery Unit for medical management over the next few days to optimize her for her coronary artery bypass graft.
The patient was taken to the operating room on [**2177-10-20**], where she underwent coronary artery bypass graft x 2 with the saphenous vein to the LAD, and the saphenous vein to the OM.
Postoperatively, she was on a dobutamine drip, as well as Insulin and propofol.
Her dobutamine drip was weaned to off, and her intra-aortic balloon pump was discontinued also on postoperative day #1.
She was weaned off of an IV Insulin drip with the assistance of the [**Last Name (un) **] consult service, and placed on subcutaneous Insulin, glargine Insulin, as well as sliding scale regular Insulin coverage, and her Insulin drip was ultimately discontinued on postoperative day #3, and she was transferred out of the Intensive Care Unit to the telemetry floor.
Her chest tubes were also discontinued at that time.
The patient received a physical therapy consult later in the day on postoperative day #3 and began to increase mobility and ambulation.
Her room air oxygen saturation was between 90 and 95%, and she was continuing to progress from a physical therapy standpoint.
The patient continued to progress with cardiac rehabilitation.
The patient also on [**10-27**], postoperative day #7, was noted to have an isolated episode of complaining of not feeling well with profuse diaphoresis.
The patient has remained hemodynamically stable over the course of the next 24 hours or so, and she is now ready to be discharged from the hospital to a rehabilitation facility to continue with cardiac rehabilitation, increasing physical therapy, and mobility.
Lopressor 25 mg po bid.
Lasix 20 mg po bid x 1 week.
Potassium chloride 20 mEq po bid x 1 week.
Colace 100 mg po bid.
Enteric-coated aspirin 325 mg po qd.
Protonix 40 mg po qd.
Dilaudid 2 mg po q 6 h prn pain.
Benadryl 25 mg po q hs prn sleep.
Amoxicillin 500 mg po bid for her chronic urinary tract infection.
12.Lantus Insulin 35 U subcu q hs.
For 201-240, she is to receive 12 [**Location **] Insulin at breakfast and lunch; she is to receive 14 U at dinner and 0 at bedtime.
A glucose of greater than 280 should be treated with 20 U at breakfast, lunch and dinner and 6 [**Location **] Insulin at bedtime.
FOLLOW-UP: 1.
She is to follow-up with her primary cardiologist, who is Dr. [**First Name (STitle) 1075**], upon discharge from rehabilitation facility.
